SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer
The FDA has announced that it had accepted the new drug application for SH-105 for the treatment of patients with breast and ovarian cancer.
Source: onclive.com
Stay updated with breaking news from Sh 105 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has announced that it had accepted the new drug application for SH-105 for the treatment of patients with breast and ovarian cancer.